Inventor · disambiguated record
Jae-Hoon Kang
Also filed as: KANG JAE-HOON
23 granted patents·11 pending applications·32 citations·filing 1993–2024
92Inventor score
Top patents by PatentIndex Score
34 records- 0189US11738064B2Pharmaceutical composition for preventing and treating eye diseases, containing as active ingredient, fusion protein in which tissue-penetrating peptide and anti-vascular endothelial growth factor preparation are fusedILDONG PHARM CO LTD·Filed 2021·Granted Aug 29, 2023·2 cites·9 claims
- 0289US9844550B2Phtalazinone derivatives and manufacturing process thereofILDONG PHARM CO LTD·Filed 2017·Granted Dec 19, 2017·6 cites·9 claims
- 0387US9682973B2Phtalazinone derivatives and manufacturing process thereofILDONG PHARM CO LTD·Filed 2014·Granted Jun 20, 2017·6 cites·7 claims
- 0485US11731961B2Phenyl propionic acid derivatives and uses thereofILDONG PHARMACEUTICAL CO LTD·Filed 2021·Granted Aug 22, 2023·1 cites·16 claims
- 0582US11052130B2Method for treating eye diseases with a fusion protein of a tissue-penetrating peptide and anti-vascular endothelial growth factorILDONG PHARM CO LTD·Filed 2017·Granted Jul 6, 2021·2 cites·5 claims
- 0680US10711345B2Hard coating film for cutting toolKORLOY INC·Filed 2017·Granted Jul 14, 2020·1 cites·2 claims
- 0779US11225472B2Phenyl propionic acid derivatives and uses thereofIL DONG PHARMA·Filed 2017·Granted Jan 18, 2022·2 cites·17 claims
- 0878US9394601B2Hard film for cutting toolKORLOY INC·Filed 2013·Granted Jul 19, 2016·2 cites·5 claims
- 0977US11268064B2Lactobacillus rhamnosus RHT-3201 conjugated to polysaccharide polymer binder, and use thereof for prevention or treatment of atopic diseasesIL DONG PHARMA·Filed 2019·Granted Mar 8, 2022·0 cites·13 claims
- 1075US2024262799A1Isoxazole derivatives as nuclear receptor agonists and uses thereofIL DONG PHARMA·Filed 2024·Application pending·0 cites
- 1172US10919947B2Pharmaceutical composition containing, as active ingredient, fusion protein in which tumor-penetrating peptide and anti-angiogenesis agent are fused, for preventing and treating cancer or angiogenesis-related diseasesIL DONG PHARMA·Filed 2018·Granted Feb 16, 2021·1 cites·10 claims
- 1269US8507109B2Multi-layer hard file for indexable insertKIM HYUNG KWUN·Filed 2009·Granted Aug 13, 2013·3 cites·3 claims
- 1367US10443033B2Lactobacillus rhamnosus RHT-3201 (KCTC 10833BP) conjugated to polysaccharide polymer binder, and use thereof for prevention or treatment of atopic diseasesIL DONG PHARMA·Filed 2016·Granted Oct 15, 2019·0 cites·8 claims
- 1465US11912674B2Isoxazole derivatives as nuclear receptor agonists and uses thereofILDONG PHARMACEUTICAL CO LTD·Filed 2021·Granted Feb 27, 2024·0 cites·13 claims
- 1565US2015307998A1Multilayer thin film for cutting tool and cutting tool including the sameKORLOY INC·Filed 2013·Application pending·0 cites
- 1662USRE49338EPhthalazinone derivatives and manufacturing process thereofIDIENCE CO LTD·Filed 2014·Granted Dec 20, 2022·0 cites·39 claims
- 1762US9752230B2Alpha alumina thin film for processing difficult-to-cut material and cast ironKORLOY INC·Filed 2014·Granted Sep 5, 2017·0 cites·5 claims
- 1860US8530205B2Buffer composition for catalyzing the preparation of calcitriol or calcifediol and method for preparing calcitriol or calcifediol using sameKANG DAE-JUNG·Filed 2011·Granted Sep 10, 2013·1 cites·7 claims
- 1959US9273388B2Hard film for cutting toolKORLOY INC·Filed 2013·Granted Mar 1, 2016·0 cites·10 claims
- 2058US10988449B2Isoxazole derivatives as nuclear receptor agonists and uses thereofIL DONG PHARMA·Filed 2018·Granted Apr 27, 2021·0 cites·12 claims
- 2155US2025343120A1Fabrication method for lead frame packaged deviceINFINEON TECHNOLOGIES AUSTRIA AG·Filed 2024·Application pending·0 cites
- 2254US8986973B2Streptococcus dysgalactiae ID9103 and method for production of hyaluronic acid using the sameILDONG PHARM CO LTD·Filed 2014·Granted Mar 24, 2015·0 cites·17 claims
- 2354US2022112185A1Novel phenyl propionic acid derivatives and uses thereofILDONG PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 2451US2021253657A1Pharmaceutical composition containing, as active ingredient, fusion protein in which tumor-penetrating peptide and antiangiogenesis agent are fused, for preventing and treating cancer or angiogenesis-related diseasesIL DONG PHARMA·Filed 2021·Application pending·0 cites
- 2547US2010168421A1A new peptide deformylase inhibitor compound and manufacturing process thereofILDONG PHARMACEUTICAL CO LTD·Filed 2008·Application pending·0 cites
- 2646US9422627B2Hard film for cutting toolKORLOY INC·Filed 2013·Granted Aug 23, 2016·0 cites·5 claims
- 2742US6063778ACephalosporin derivatives and processes for the preparation thereofIL DONG PHARMA·Filed 1996·Granted May 16, 2000·3 cites·4 claims
- 2841US2008039438A11B-Methylcarbapenem Derivative and Process for the Preparation ThereofKOREA INST SCI & TECH·Filed 2005·Application pending·0 cites
- 2940US2008234333A1Novel Hydroxamic Acid Derivative as Peptide Deformylase Inhibitor and Manufacturing Method ThereofKANG JAE-HOON·Filed 2006·Application pending·0 cites
- 3038US10894086B2Functional hydrated hyaluronic acid and method for producing coated lactic acid bacteria having excellent intestinal mucoadhesive ability and selective antagonistic action using sameILDONG PHARMACEUTICAL CO LTD·Filed 2016·Granted Jan 19, 2021·0 cites·7 claims
- 3138US2016009828A1Preparation method for hyaluronic acid, and anti-adhesive composition comprising hyaluronic acid prepared by same preparation methodILDONG PHARM CO LTD·Filed 2015·Application pending·0 cites
- 3236US5663331ACephalosporin compoundsIL DONG PHARMA·Filed 1993·Granted Sep 2, 1997·2 cites·4 claims
- 3335US2012232261A1Method for manufacturing low molecular weight hyaluronic acidKANG DAE-JUNG·Filed 2012·Application pending·0 cites
- 3432US2012309750A15-membered heterocycle derivatives and manufacturing process thereofKANG JAE-HOON·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jae-Hoon Kang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →